Why Doximity, Inc.’s (DOCS) Stock Is Up 6.73%

By Rosalio Madrigal
August 02, 2026
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Doximity, Inc. before investing.

In this article, we go over a few key elements for understanding Doximity, Inc.’s stock price such as:

  • Doximity, Inc.’s current stock price and volume
  • Why Doximity, Inc.’s stock price changed recently
  • Upgrades and downgrades for DOCS from analysts
  • DOCS’s stock price momentum as measured by its relative strength

About Doximity, Inc. (DOCS)

Before we jump into Doximity, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Want to learn more about Doximity, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Doximity, Inc..

Learn More About A+ Investor

Doximity, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Doximity, Inc.’s stock price was $20.910.

Doximity, Inc. is down 1.55% from its previous closing price of $21.240.

During the last market session, Doximity, Inc.’s stock traded between $20.710 and $21.360. Currently, there are approximately 184.85 million shares outstanding for Doximity, Inc..

Doximity, Inc.’s price-earnings (P/E) ratio is currently at 21.3, which is low compared to the Health Care Technology industry median of 36.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Doximity, Inc. Stock Price History

Doximity, Inc.’s (DOCS) price is currently up 0.82% so far this month.

During the month of July, Doximity, Inc.’s stock price has reached a high of $23.570 and a low of $20.070.

Over the last year, Doximity, Inc. has hit prices as high as $76.510 and as low as $17.150. Year to date, Doximity, Inc.’s stock is down 52.78%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Doximity, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded Doximity, Inc.’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Doximity, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Doximity, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Doximity, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Doximity, Inc. (DOCS) by visiting AAII Stock Evaluator.

Relative Price Strength of Doximity, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Doximity, Inc. has a weighted four-quarter relative price strength of -22.80%, which translates to a Momentum Score of 10 and is considered to be Very Weak.

Want to learn more about how Doximity, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Doximity, Inc. Stock Price: Bottom Line

As of July 31, 2026, Doximity, Inc.’s stock price is $20.910, which is down 1.55% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Doximity, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
High Relative Dividend
Yield Screen:
8.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.